ArticleCell reports. Medicine2026
Subretinal rAAV2-based VEGF-Trap gene therapy for neovascular age-related macular degeneration: Preclinical assessment and phase 1 trial results.
Tong Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.